Levitee Labs Signs Letter Of Intent To Acquire Calgary Addiction & Compounding Pharmacy

Levitee Labs Inc. (Levitee), an integrative wellness company with a diversified portfolio of health care and wellness assets, has signed a letter of intent (LOI) to acquire 51% of the issued and outstanding shares in a compounding pharmacy in Calgary, Alberta, Canada. Levitee expects to fund this acquisition using its current cash reserves.

This pharmacy will be used as an initial base for the production and distribution of pharmaceutical products for Levitee Labs, which will include pain and depression management products such as ketamine. Levitee plans to expand operations by introducing a research laboratory for the development and production of . . .